Skip to main content

Table 1 Demographic data and baseline hemodynamic measurements in the three groups of patients

From: The influence of the infusion of ephedrine and phenylephrine on the hemodynamic stability after subarachnoid anesthesia in senior adults - a controlled randomized trial

GROUP

C

P

E

p value

Number of patients

21

24

25

 

Gender (male/female)

5/16

8/16

5/20

0.55

Age (years)

67.9 (± 5.5)

71.1 (± 7.7)

68.4 (± 6.6)

0.209

Height (cm)

166.2 (± 8.2)

158.8 (± 34.6)

164.6 (± 11.5)

0.477

Weight (kg)

79.7 (± 13.5)

86.0 (± 13.6)

82.1 (± 14.2)

0.305

ASA I/ ASA II/ ASA III

3/12/6

2/15/7

1/17/7

0.803

BMI

28.8 (± 4.5)

31.3 (± 5.0)

30.2 (± 3.9)

0.195

BSA

1.9 (± 0.2)

1.9 (± 0.2)

1.9 (± 0.2)

0.54

SBP (mmHg)a

134 (± 22)

128 (± 17)

125 (± 15)

0.194

MAP (mmHg)a

90 (± 12)

85 (± 12)

84 (± 9)

0.156

HR (beats/min) a

75.4 (± 11.0)

73.5 (± 11.6)

74.7 (± 11.7)

0.856

CI (BSA) (l/min/m2) a

2.5 (± 0.7)

2.2 (± 0.5)

2.5 (± 0.6)

0.219

SVR (din s cm− 5) a

886 (± 292)

863 (± 233)

850 (± 320)

0.911

SVI (ml/m2) a

33.1 (± 5.8)

30.3 (± 6.0)

32.8 (± 6.7)

0.255

  1. SBPsystolic blood pressure, MAPmean arterial pressure, CO cardiac output,
  2. SVRsystemic vascular resistance
  3. Values are mean (± SD)
  4. a Baseline values defined as last registered values before SA